Richard J. Kaufman
- Oncology top 5%
- Cardiology and Cardiovascular Medicine top 10%
- Surgery
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Co-authors
- Violante E. CurrieDavid W. KinneThomas B. HakesPaul Peter RosenHarry GrabstaldPhilip LiebermanSaul KayDavid W. Braun
- Topics
- Cancer Treatment and Pharmacology (10 papers)Cancer, Lipids, and Metabolism (7 papers)Estrogen and related hormone effects (7 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Richard J. Kaufman
33 papers receiving 995 citations
Peers
Comparison fields: 5 of 93
- Oncology 553
- Cardiology and Cardiovascular Medicine 293
- Surgery 261
- Pulmonary and Respiratory Medicine 205
- Cancer Research 187
Countries citing papers authored by Richard J. Kaufman
This map shows the geographic impact of Richard J. Kaufman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Kaufman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Kaufman more than expected).
Fields of papers citing papers by Richard J. Kaufman
This network shows the impact of papers produced by Richard J. Kaufman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Kaufman. The network helps show where Richard J. Kaufman may publish in the future.
Co-authorship network of co-authors of Richard J. Kaufman
This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Kaufman. A scholar is included among the top collaborators of Richard J. Kaufman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Kaufman. Richard J. Kaufman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 5 | |
| 3 | 27 | |
| 4 | 9 | |
| 5 | 69 | |
| 6 | 68 | |
| 7 | 8 | |
| 8 | Phase II evaluation of orally administered idarubicin in patients with advanced breast cancer. | 12 |
| 9 | 2 | |
| 10 | 195 | |
| 11 | Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer. | 7 |
| 12 | Aclacinomycin-A: Phase I trial in patients with solid tumors | 0 |
| 13 | 14 | |
| 14 | 37 | |
| 15 | Criteria for evaluating hormones in the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor-rat experimental chemotherapy system. | 11 |
| 16 | 22 | |
| 17 | Biologic characteristics and chemotherapy of 7,12-dimethylbenz[a]anthracene-induced tumors in rats. | 39 |
| 18 | 16 | |
| 19 | 5 | |
| 20 | 30 |
About Richard J. Kaufman
Richard J. Kaufman is a scholar working on Cancer Research, Oncology and Pharmacy, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Cancer, Lipids, and Metabolism (7 papers) and Estrogen and related hormone effects (7 papers). The work is most often cited by research in Oncology (553 citations), Dermatology (115 citations) and Cardiology and Cardiovascular Medicine (293 citations). Richard J. Kaufman has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Violante E. Currie, David W. Kinne, Thomas B. Hakes, Paul Peter Rosen, Harry Grabstald, Philip Lieberman, Saul Kay, David W. Braun, E. S. Casper and George C. Escher. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.